FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Merck Sharp & Dohme LLC
St. Jude Children's Research Hospital
Allogene Therapeutics
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
M.D. Anderson Cancer Center
Gilead Sciences
UNC Lineberger Comprehensive Cancer Center
Sana Biotechnology
Celgene
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Gilead Sciences
Sana Biotechnology
Gilead Sciences
Chinese PLA General Hospital
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Artiva Biotherapeutics, Inc.
Synthekine
Stanford University
Baylor College of Medicine
Shanghai Ming Ju Biotechnology Co., Ltd.
National Institutes of Health Clinical Center (CC)
Columbia University
University of Birmingham
Tessa Therapeutics
Loyola University